Broomfield’s Regenerative Sciences announced today it has secured a $2 million investment from John Malone, chairman of Liberty Media Corp.
The company said that in addition to advancing Regenerative Sciences’ clinical and lab-based stem-cell research, the investment will help support the national expansion of its Regenexx Physician Network.
The company said that its Regenexx procedures utilize a patient’s own stem cells to help repair a broad range of common injuries and degenerative conditions, including cartilage lesions, torn ligaments and tendons and bulging spinal discus.
“We are proud of our accomplishments in the field of regenerative interventional orthopedics and it’s exciting that our work has drawn the attention of such a noted entrepreneur and philanthropist,” said Dr. Christopher J. Centeno, chief executive of Regenerative Sciences.
“Dr. Malone shares our vision for forging the next generation of minimally invasive regenerative treatments,” Centeno added.
Centeno said Malone’s investment will bolster the company’s existing stem-cell research programs and make the firm’s procedures available throughout the United States.
Howard Pankratz: 303-954-1939 or hpankratz@denverpost.com or twitter@Howard Pankratz
